{"id":"W4408803504","doi":"10.1016/j.annonc.2025.03.010","title":"Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"Gilead Sciences; Novartis","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Palbociclib; Internal medicine; Cancer; Placebo; Gynecology; Pathology; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00135024,0.00093359,0.002067632,0.0002957881,0.000221435,0.001139593,0.0005739797,0.0007579116,0.005666573],"category_scores_gemma":[0.001752765,0.0002393607,0.002102213,0.0003218256,0.0004629428,0.0007926335,0.0002812999,0.002727141,0.0005888155],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009676965,"about_ca_system_score_gemma":0.0006149758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001093676,"about_ca_topic_score_gemma":0.003292595,"domain_scores_codex":[0.999546,0.000245736,0.00002417808,0.00006993891,0.00003197636,0.00008223137],"domain_scores_gemma":[0.999292,0.0002989748,0.0001267504,0.00004576985,0.00004141849,0.0001949591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9266496,0.001380199,0.002146134,0.001693636,0.004015953,0.0000954623,0.00005100737,0.002123449,0.002497449,0.0003040558,0.004141327,0.05490172],"study_design_scores_gemma":[0.8293779,0.1136342,0.03231999,0.0006254824,0.009783155,0.0003300367,0.0001627241,0.002710151,0.001754972,0.001853757,0.007378799,0.00006882245],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9358001,0.04487207,0.0006337135,0.002121747,0.0009248777,0.0006814147,0.003946073,0.0001363998,0.01088357],"genre_scores_gemma":[0.9831396,0.006584347,0.0003430648,0.001539918,0.0003336011,0.0003573474,0.003357346,0.00002614463,0.004318732],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005666573,"threshold_uncertainty_score":0.0189566,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05246479190285808,"score_gpt":0.3622241662839321,"score_spread":0.309759374381074,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}